Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China · Delayed Price · Currency is CNY 7.64
+0.45 (6.26%)
At close: Sep 1, 2025
SHA:688373 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Net Income | -378.09 | -440.72 | -421.12 | -220.3 | -226.27 | -86.33 | Upgrade |
Depreciation & Amortization | 14.15 | 14.17 | 14.12 | 15.3 | 12.11 | 0.47 | Upgrade |
Other Amortization | 3.81 | 3.49 | 3.71 | 2.17 | 1.6 | 1.25 | Upgrade |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0 | -0.49 | 0.02 | 0 | Upgrade |
Asset Writedown & Restructuring Costs | -0 | - | - | - | - | 0.01 | Upgrade |
Loss (Gain) From Sale of Investments | -11.41 | -17.08 | -33.34 | -18.49 | -10.53 | -2.27 | Upgrade |
Stock-Based Compensation | 35.16 | 37.53 | 37.14 | 28.22 | 45.39 | 10.84 | Upgrade |
Provision & Write-off of Bad Debts | 0.9 | 0.77 | 0.33 | 0.2 | 0.03 | 0.01 | Upgrade |
Other Operating Activities | 12.28 | 12.88 | 9.18 | 7.06 | 5.13 | 4.85 | Upgrade |
Change in Accounts Receivable | -13.82 | -24.41 | 11.47 | -58.49 | -14.76 | -17.9 | Upgrade |
Change in Inventory | -7.93 | -15.42 | -15.63 | -10.88 | -5.58 | -5.61 | Upgrade |
Change in Accounts Payable | 5.62 | -18.87 | 66.92 | 28.71 | 11.28 | -3.65 | Upgrade |
Change in Unearned Revenue | 0.5 | 0.5 | -1.85 | -13 | 0.6 | 4.35 | Upgrade |
Change in Other Net Operating Assets | - | - | - | - | - | 4.62 | Upgrade |
Operating Cash Flow | -338.86 | -447.18 | -329.08 | -240.01 | -180.98 | -89.34 | Upgrade |
Capital Expenditures | -1.13 | -0.91 | -7.66 | -12.18 | -22.91 | -0.8 | Upgrade |
Sale of Property, Plant & Equipment | -0 | 0.03 | - | 1.5 | - | - | Upgrade |
Investment in Securities | 347.26 | 495.51 | 305.24 | -737.6 | 35 | -380 | Upgrade |
Other Investing Activities | 8.06 | 20.17 | 37.05 | 14.86 | 10.11 | 2.02 | Upgrade |
Investing Cash Flow | 354.2 | 514.8 | 334.63 | -733.42 | 22.2 | -378.78 | Upgrade |
Long-Term Debt Issued | - | 105 | 60 | 148.75 | 53.25 | 6.6 | Upgrade |
Long-Term Debt Repaid | - | -32.34 | -75.01 | -84.35 | -19.33 | - | Upgrade |
Net Debt Issued (Repaid) | 79.04 | 72.66 | -15.01 | 64.4 | 33.92 | 6.6 | Upgrade |
Issuance of Common Stock | 1.98 | 1.98 | - | 981.77 | 5.09 | 665.17 | Upgrade |
Common Dividends Paid | - | - | -4.6 | -3.3 | -0.7 | - | Upgrade |
Other Financing Activities | -8.18 | -6.54 | - | -14.72 | -10.63 | 0.44 | Upgrade |
Financing Cash Flow | 72.83 | 68.09 | -19.61 | 1,028 | 27.68 | 672.22 | Upgrade |
Foreign Exchange Rate Adjustments | 0.27 | 0.14 | 0.45 | 1.16 | -0.2 | -0.01 | Upgrade |
Net Cash Flow | 88.44 | 135.86 | -13.61 | 55.88 | -131.3 | 204.1 | Upgrade |
Free Cash Flow | -339.99 | -448.1 | -336.74 | -252.18 | -203.89 | -90.14 | Upgrade |
Free Cash Flow Margin | -249.07% | -343.97% | -370.96% | -523.13% | -2661.81% | - | Upgrade |
Free Cash Flow Per Share | -0.51 | -0.68 | -0.51 | -0.43 | -0.39 | -0.35 | Upgrade |
Cash Interest Paid | 10.85 | 6.54 | - | - | - | 2.43 | Upgrade |
Cash Income Tax Paid | 12.1 | 27 | -9.87 | -7.2 | 0.39 | 0.47 | Upgrade |
Levered Free Cash Flow | -206.28 | -286.51 | -172.29 | -178.87 | -141.67 | -74.66 | Upgrade |
Unlevered Free Cash Flow | -198.5 | -279.54 | -165.95 | -173.36 | -138.4 | -73.14 | Upgrade |
Change in Working Capital | -15.63 | -58.2 | 60.9 | -53.67 | -8.47 | -18.19 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.